Alzamend Neuro, INC. (ALZN) SEC Filings — 2024
29 SEC filings for Alzamend Neuro, INC. (ALZN) in 2024.
Filings
- Alzamend Neuro Files 8-K on Financials — 8-K · Dec 12, 2024
- Alzamend Neuro Files 10-Q for Q2 2024 — 10-Q · Dec 11, 2024
- Alzamend Neuro Files 8-K with Financial Updates — 8-K · Oct 15, 2024
- Alzamend Neuro Enters Material Definitive Agreement — 8-K · Oct 3, 2024
- Alzamend Neuro Files 10-Q for Period Ending July 31, 2024 — 10-Q · Sep 11, 2024
- Alzamend Neuro Files 8-K — 8-K · Jul 31, 2024
- Alzamend Neuro Files 2024 10-K — 10-K · Jul 30, 2024
- Alzamend Neuro Files 8-K with Corporate Updates — 8-K · Jul 12, 2024
- Alzamend Neuro Files 8-K on Shareholder Votes and Financials — 8-K · Jul 8, 2024
- Alzamend Neuro Files S-1/A Amendment — S-1/A · Jul 3, 2024
- Alzamend Neuro Files S-1/A Amendment — S-1/A · Jun 26, 2024
- Alzamend Neuro Files Proxy Statement Amendment — DEFA14A · Jun 11, 2024
- Alzamend Neuro Files S-1 for Potential Stock Offering — S-1 · Jun 3, 2024
- Alzamend Neuro Files Proxy Statement for Annual Meeting — DEF 14A · May 31, 2024
- Alzamend Neuro Files 8-K — 8-K · May 22, 2024
- Alzamend Neuro Files 8-K — 8-K · May 15, 2024
- Alzamend Neuro Files 8-K for Financial Statements — 8-K · May 13, 2024
- Alzamend Neuro Files 8-K/A Amendment — 8-K/A · May 10, 2024
- Alzamend Neuro Changes Independent Accountants — 8-K · May 9, 2024
- Alzamend Neuro Terminates Material Agreement — 8-K · May 7, 2024
- Alzamend Neuro Files 8-K on Voting Matters and Financials — 8-K · May 1, 2024
- Alzamend Neuro Files 8-K: Material Agreement & Equity Sales — 8-K · Apr 30, 2024
- Alzamend Neuro Faces Delisting, Reports Equity Sales — 8-K · Mar 29, 2024
- Alzamend Neuro, Inc. Files 10-Q for Period Ending January 31, 2024 — 10-Q · Mar 25, 2024
- Alzamend Neuro Files 8-K for Material Agreements — 8-K · Mar 22, 2024
- Alzamend Neuro Files 8-K with Bylaw Amendments — 8-K · Mar 7, 2024
- Alzamend Neuro Faces Delisting, Sells Unregistered Equity — 8-K · Feb 2, 2024
- Ault Group Files 4th Amendment on Alzamend Neuro Stake — SC 13D/A · Jan 25, 2024
- Alzamend Neuro 8-K: Executive Compensation Arrangements Updated — 8-K · Jan 5, 2024